Allworth Financial LP Neurocrine Biosciences Inc Transaction History
Allworth Financial LP
- $16.1 Billion
- Q3 2024
A detailed history of Allworth Financial LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Allworth Financial LP holds 136 shares of NBIX stock, worth $17,100. This represents 0.0% of its overall portfolio holdings.
Number of Shares
136
Previous 234
41.88%
Holding current value
$17,100
Previous $32,000
53.13%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding NBIX
# of Institutions
617Shares Held
94.7MCall Options Held
583KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.78 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.26 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$579 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$310 Million0.6% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.9MShares$239 Million4.37% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...